JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, vol.111, no.3, pp.262-269, 2019 (SCI-Expanded)
Article / Article
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION
Science Citation Index Expanded (SCI-EXPANDED), Scopus
Ankylosing spondylitis, Anti-TNF-alfa, Paradoxical adverse events, Inflammatory bowel disease, NECROSIS FACTOR THERAPY, JUVENILE IDIOPATHIC ARTHRITIS, EXTRAARTICULAR MANIFESTATIONS, GUT INFLAMMATION, ADVERSE EVENTS, NEW-ONSET, SPONDYLOARTHROPATHIES
Eskisehir Osmangazi University Affiliated:
Objective: The aim of this study was to determine whether there is any association with anti-tumor necrosis factor (TNF) agent administration and development of new-onset inflammatory bowel disease (IBD) in ankylosing spondylitis (AS) patients.